Migraines & headaches decisions — 2025

The Board granted an initial 50 percent rating for posttraumatic headaches, effective June 13, 2020, resolving all doubt in the Veteran's favor.

The Board granted a 50 percent disability rating for tension headaches but denied an increased rating greater than 10 percent for scars, lower left extremity, left ankle and left heel. The claim for a disability rating greater than 10 percent for GERD was remanded.

The Board granted service connection for left shoulder strain, right knee strain, and migraine including migraine variants. The claim for an initial disability rating of 30 percent for cervical strain with degenerative arthritis was also granted.

The Board granted service connection for tinnitus and tension headaches, but denied service connection for chronic fatigue syndrome, restless leg syndrome, sinusitis, abdominal pain syndrome, higher ratings for PTSD and knee conditions, and a compensable rating for dermatitis.

The Veteran withdrew appeals for service connection of multiple conditions, resulting in the dismissal of all claims.

The Board denied the veteran's claims for increased ratings and an earlier effective date, finding that the evidence did not support higher disability ratings or a more favorable effective date.

The Board remands the claim for service connection for headaches to correct a pre-decisional duty to assist error, as the previous VA examiner's opinion was found inadequate.

The Board granted service connection for migraine headaches, right knee strain with post-traumatic arthritis, and right foot post-traumatic arthritis based on the evidence of record.

The Board granted an initial rating of 10 percent for migraine headaches, resolving all doubt in the Veteran's favor.

The Board remands the claims for an initial rating in excess of 10 percent for GERD and a compensable rating for migraines with migraine variants due to deficiencies in the VA examinations.

The appeal for service connection for migraine headaches was withdrawn by the Veteran prior to the scheduled hearing, and thus has been dismissed.

The Veteran withdrew all pending claims and chose to pursue subsequently filed supplemental claims for the same conditions.

The Board denied the veteran's claims for a compensable rating for erectile dysfunction and migraine headaches, as the evidence did not support a higher rating under the applicable criteria.

The Board denied the veteran's claims for increased ratings for peripheral vestibular disorder, headaches, and PTSD with major depression and residuals from a TBI.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support a compensable evaluation for left ear hearing loss or right ear hearing loss, an evaluation in excess of 30 percent disabling for headaches, or an evaluation in excess of 10 percent disabling for sinus bradycardia/sinus arrhythmia. The claims for service connection for hemorrhoids, hypertension, keratosis pilaris (skin condition), neck pain, and allergies/sinus condition were remanded.

The Board granted service connection for headaches, finding new and relevant evidence favorable to the veteran.

The Board granted service connection for a left ankle disability, cervical spine disability, and migraine headache disability. The appeal regarding the lumbosacral strain was remanded.

The Board granted service connection for a migraine disability, finding that new and relevant evidence had been submitted since the previous denial in July 2014.

The Board granted an effective date of May 29, 2017 for the award of service connection for fibromyalgia and a 60 percent rating for genital herpes, while denying higher ratings for migraine headaches and PTSD with borderline personality disorder.

The Board denied service connection for various conditions, including dental trauma, chronic respiratory failure, headaches, allergic rhinitis and sinusitis, low back disability, left ankle disability, right ankle disability, hemorrhoids, epigastric pain, thyroid disability, monoclonal paraproteinemia, and hip disabilities.